Related Experiment Video
Updated: May 17, 2026

07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Gene-expression-based cancer subtypes prediction through feature selection and transductive SVM
Ujjwal Maulik1, Anirban Mukhopadhyay, Debasis Chakraborty
1Department of Computer Science and Engineering, Jadavpur University, Kolkata 700032, India. umaulik@cse.jdvu.ac.in
IEEE Transactions on Bio-Medical Engineering
|October 26, 2012
Summary
This study introduces a novel method combining gene selection and transductive support vector machines (TSVMs) for cancer classification. The approach effectively identifies gene markers and improves prediction accuracy using limited labeled data.
Area of Science:
- Bioinformatics
- Cancer Genomics
- Machine Learning in Medicine
Background:
- Microarray technology enables gene expression profiling for cancer outcome prediction.
- Classifying cancer subtypes and identifying diagnostic gene markers are crucial but challenged by small sample sizes.
- Traditional supervised learning requires fully labeled data, often excluding valuable unlabeled microarray datasets.
Purpose of the Study:
- To propose a novel approach integrating feature (gene) selection with transductive support vector machines (TSVMs).
- To identify potential gene markers for cancer subtypes.
- To enhance cancer classification accuracy using semisupervised learning.
Main Methods:
- A forward greedy search algorithm based on consistency and signal-to-noise ratio was used for gene selection.
- Selected genes were utilized to design a TSVM classifier.
- The proposed method was compared against standard inductive SVMs (ISVMs) and low-density separation.
Main Results:
- The study successfully identified potential gene markers associated with cancer subtypes.
- TSVMs demonstrated improved prediction accuracy compared to ISVMs.
- The proposed semisupervised technique proved effective for cancer classification and gene-marker identification.
Conclusions:
- Combining gene selection with TSVMs offers a powerful strategy for cancer classification, especially with limited labeled data.
- The developed method enhances diagnostic capabilities through accurate gene-marker identification.
- This approach effectively leverages unlabeled microarray data, overcoming a significant bottleneck in cancer research.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
